Illumina (ILMN) Cash & Equivalents (2009 - 2026)

Illumina has reported Cash & Equivalents for 18 years, with the latest figure at $1.1 billion in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 2.16% year-over-year to $1.1 billion; the trailing twelve-month figure through Mar 2026 stood at $1.1 billion (down 2.16% YoY), and the FY2025 full-year result was $1.4 billion, up 25.82% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $1.1 billion, down from $1.4 billion in the prior quarter.
• The five-year high for Cash & Equivalents was $2.0 billion in Q1 2023, with the low at $869.0 million in Q3 2024.
• Historically, Cash & Equivalents has averaged $1.2 billion across 5 years, with a median of $1.1 billion in 2024.
• Annual changes were most pronounced in 2022 — Cash & Equivalents sank 69.52% — and 2023, when it surged 63.23%.
• Illumina's Cash & Equivalents stood at $1.0 billion in 2022, then climbed by 4.8% to $1.0 billion in 2023, then grew by 7.54% to $1.1 billion in 2024, then advanced by 25.82% to $1.4 billion in 2025, then fell by 23.2% to $1.1 billion in 2026.
• The last three Cash & Equivalents figures came in at $1.1 billion (Q1 2026), $1.4 billion (Q4 2025), and $1.0 billion (Q3 2025), per Business Quant data.